U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017790) titled 'Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas' on June 04.
Brief Summary: Amino acid PET imaging could represent a biomarker for the evaluation of IDH inhibitor treatments for patients with refractory IDH-mutated gliomas
Study Start Date: June 30
Study Type: OBSERVATIONAL
Condition:
Glioma
Intervention:
OTHER: Amino-acid PET
Patients received 18-fluoroDopa then a PET exam
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Central Hospital, Nancy, France
Information provided by (Responsible Party): Antoine VERGER, Central Hospital, Nancy, France
Published by HT Digital Content Servi...